POINT Biopharma Global Inc. (PNT) NASDAQ
$13.71 0.03 (0.22%)
Market Cap: -
As of 11/20/23 04:00 PM EST. Market closed.
POINT Biopharma Global Inc. (PNT)
NASDAQ
$13.71
0.03 (0.22%)
Market Cap: -
As of 11/20/23 04:00 PM EST. Market closed.
Add to Portfolio
a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient ... read more
a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joe A. McCann
Full Time Employees
74,952
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joe A. McCann
Full Time Employees
74,952
Address
4850 West 78th Street, IN, Indianapolis, 46268.
PRICE CHART FOR POINT BIOPHARMA GLOBAL INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$13.68
Days Range
$13.36 - $13.78
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
106,569,231
Open
-
Previous Close
$13.68
Days Range
$13.36 - $13.78
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
106,569,231
FINANCIAL STATEMENTS FOR POINT BIOPHARMA GLOBAL INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR POINT BIOPHARMA GLOBAL INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BVF PARTNERS L P/IL | Former 10% Owner | Dec 18, 2023 | Sale | $12.45 | 17,161,278 | 213,657,908 | 0 | Dec 20, 2023, 06:09 PM |
| HOGUE GERALD L. | Director | Mar 21, 2023 | Option Exercise | $6.97 | 17,936 | 125,014 | 21,596 | Mar 23, 2023, 08:09 PM |
| MCCANN JOE A. | Chief Executive Officer | Nov 29, 2022 | Buy | $6.64 | 2,160 | 14,342 | 3,616,313 | Nov 30, 2022, 07:56 PM |
| Lubner David Charles | Director | Nov 23, 2022 | Buy | $6.85 | 3,600 | 24,660 | 3,600 | Nov 28, 2022, 04:03 PM |
| HOGUE GERALD L. | Director | Nov 25, 2022 | Buy | $6.82 | 3,660 | 24,943 | 3,660 | Nov 28, 2022, 04:02 PM |
| Malik Rajesh | Director | Nov 28, 2022 | Buy | $6.66 | 3,700 | 24,642 | 3,700 | Nov 28, 2022, 04:01 PM |
| MARGOLIN YAEL | Director | Nov 21, 2022 | Buy | $6.56 | 1,710 | 11,218 | 1,710 | Nov 23, 2022, 12:43 PM |
| GOODMAN JONATHAN R. | Director | Nov 18, 2022 | Buy | $6.33 | 6,000 | 37,980 | 41,872 | Nov 21, 2022, 05:54 PM |
| SILBER ALLAN C | Executive Chairman | Nov 18, 2022 | Buy | $6.50 | 22,397 | 145,581 | 4,268,605 | Nov 21, 2022, 05:52 PM |
| SILBER ALLAN C | Executive Chairman | Nov 17, 2022 | Buy | $6.00 | 27,603 | 165,618 | 4,246,208 | Nov 21, 2022, 05:52 PM |
| FLESHNER NEIL E. | Chief Medical Officer | May 25, 2022 | Sale | $7.51 | 564,204 | 4,237,172 | 3,023,045 | May 26, 2022, 04:05 PM |
| Kolchinsky Peter | Chief Executive Officer | Jun 29, 2021 | Option Exercise | $10.00 | 209,100 | 2,091,000 | 1,098,318 | Jun 30, 2021, 04:31 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jun 29, 2021 | Buy | $10.00 | 209,100 | 2,091,000 | 1,098,318 | Jun 30, 2021, 04:30 PM |
| Kolchinsky Peter | Chief Executive Officer | Jun 24, 2021 | Option Exercise | $10.00 | 889,218 | 8,892,180 | 889,218 | Jun 24, 2021, 07:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BVF PARTNERS L P/IL | Former 10% Owner | 12/18/2023 | 213,657,908 |
| HOGUE GERALD L. | Director | 03/21/2023 | 125,014 |
| MCCANN JOE A. | Chief Executive Officer | 11/29/2022 | 14,342 |
| Lubner David Charles | Director | 11/23/2022 | 24,660 |
| HOGUE GERALD L. | Director | 11/25/2022 | 24,943 |
| Malik Rajesh | Director | 11/28/2022 | 24,642 |
| MARGOLIN YAEL | Director | 11/21/2022 | 11,218 |
| GOODMAN JONATHAN R. | Director | 11/18/2022 | 37,980 |
| SILBER ALLAN C | Executive Chairman | 11/18/2022 | 145,581 |
| SILBER ALLAN C | Executive Chairman | 11/17/2022 | 165,618 |
| FLESHNER NEIL E. | Chief Medical Officer | 05/25/2022 | 4,237,172 |
| Kolchinsky Peter | Chief Executive Officer | 06/29/2021 | 2,091,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 06/29/2021 | 2,091,000 |
| Kolchinsky Peter | Chief Executive Officer | 06/24/2021 | 8,892,180 |
Load More Insider Transactions
FUNDS WITH A POSITION IN POINT BIOPHARMA GLOBAL INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| JET CAPITAL INVESTORS L P | 164,600 (Call) | 4.04% | New | Event Driven |
| JET CAPITAL INVESTORS L P | 2,800 (Put) | 0.07% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR POINT BIOPHARMA GLOBAL INC
STOCK BUYBACKS FOR POINT BIOPHARMA GLOBAL INC
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0.06%
1Q
12/31/2022
-5.15%
2Q
09/30/2022
14.42%
3Q
06/30/2022
17.31%
4Q
03/31/2022
17.31%
5Q
12/31/2021
43.16%
6Q
09/30/2021
17.31%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR POINT BIOPHARMA GLOBAL INC
LOADING...